American Drug Index 1994 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download American Drug Index 1994 PDF full book. Access full book title American Drug Index 1994 by Norman F. Billups. Download full books in PDF and EPUB format.
Author: Norman F. Billups
Publisher:
ISBN: 9780932686312
Category : Drugs
Languages : en
Pages : 900
Get Book Here
Book Description
Author: Norman F. Billups
Publisher:
ISBN: 9780932686312
Category : Drugs
Languages : en
Pages : 900
Get Book Here
Book Description
Author: Thomas S. Weinberg
Publisher: SAGE Publications
ISBN: 1506304680
Category : Social Science
Languages : en
Pages : 460
Get Book Here
Book Description
The American Drug Culture uses sociological and other perspectives to examine drug and alcohol use in U.S. society. The text is arranged topically rather than by drug categories and explores diverse aspects of drug use, including popular culture, sexuality, legal and criminal justice systems, other social institutions, and mental and physical health. It covers alcohol, the most widely used drug in the United States, more extensively than other texts on this subject. The authors include case studies from their own field research that give students empathetic insights into the situations of those suffering from substance and alcohol abuse.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Get Book Here
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author: Lippincott Williams & Wilkins
Publisher: Lippincott Williams & Wilkins
ISBN: 1975160150
Category : Medical
Languages : en
Pages : 2933
Get Book Here
Book Description
THE #1 Drug Guide for nurses & other clinicians...always dependable, always up to date! Look for these outstanding features: Completely updated nursing-focused drug monographs featuring 3,500 generic, brand-name, and combination drugs in an easy A-to-Z format NEW 32 brand-new FDA-approved drugs in this edition, including the COVID-19 drug remdesivir—tabbed and conveniently grouped in a handy “NEW DRUGS” section for easy retrieval NEW Thousands of clinical updates—new dosages and indications, Black Box warnings, genetic-related information, adverse reactions, nursing considerations, clinical alerts, and patient teaching information Special focus on U.S. and Canadian drug safety issues and concerns Photoguide insert with images of 439 commonly prescribed tablets and capsules
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 838
Get Book Here
Book Description
Monographs provide manufacturer, generic name, preparation and size availability. Also includes chapters on container and storage requirements, dosage forms that should not be crushed, and a list of distributors.
Author: Muller
Publisher: CRC Press
ISBN: 3769221141
Category : Medical
Languages : en
Pages : 776
Get Book Here
Book Description
This fourth edition of the European Drug Index provides information about drugs available on the European market arranged alphabetically by trade name, including
Author: Meredith A. Hickmann
Publisher: Nova Publishers
ISBN: 9781590333877
Category : Business & Economics
Languages : en
Pages : 212
Get Book Here
Book Description
The FDA is responsible for ensuring the safety of foods, drugs, medical devices, cosmetics, and a variety of other products. These products account for 25 cents of every dollar US consumers spend. Under the authority of the Federal Food, Drug, and Cosmetic Act, FDA is responsible for ensuring that these products are safe, accurately labelled, and in the case of drugs and medical devices, effective. FDA's tasks include: enforcement, pre-market product evaluation and approval, post-market surveillance and investigations, publishing of regulations, conducting and monitoring of research, public education, and regulating products and processes to prevent hazards to human health. Contents: Preface; Food and Drug Administration: Selected Funding Data; Food and Drug Administration: Selected Funding and Policy Issues; US European Agricultural Trade: Food and Biotechnology Issues; Food and Drug Administration: Selected Funding and Policy Issues; Food and Drug Administration Modernisation Act of 1997 -- The Provisions; Index.
Author: George B. Griffenhagen
Publisher: Amer. Inst. History of Pharmacy
ISBN: 9780931292262
Category : Medical
Languages : en
Pages : 164
Get Book Here
Book Description
Author: Horace A. Bartilow
Publisher: UNC Press Books
ISBN: 1469652560
Category : Political Science
Languages : en
Pages : 321
Get Book Here
Book Description
In this book, Horace Bartilow develops a theory of embedded corporatism to explain the U.S. government's war on drugs. Stemming from President Richard Nixon's 1971 call for an international approach to this "war," U.S. drug enforcement policy has persisted with few changes to the present day, despite widespread criticism of its effectiveness and of its unequal effects on hundreds of millions of people across the Americas. While researchers consistently emphasize the role of race in U.S. drug enforcement, Bartilow's empirical analysis highlights the class dimension of the drug war and the immense power that American corporations wield within the regime. Drawing on qualitative case study methods, declassified U.S. government documents, and advanced econometric estimators that analyze cross-national data, Bartilow demonstrates how corporate power is projected and embedded—in lobbying, financing of federal elections, funding of policy think tanks, and interlocks with the federal government and the military. Embedded corporatism, he explains, creates the conditions by which interests of state and nonstate members of the regime converge to promote capital accumulation. The subsequent human rights repression, illiberal democratic governments, antiworker practices, and widening income inequality throughout the Americas, Bartilow argues, are the pathological policy outcomes of embedded corporatism in drug enforcement.
